You Must See This Company In A Potential $245 Billion Market(1)
Supported by the Bill and Melinda Gates Foundation(2), AI/ML Innovations Subsidiary, Health Gauge’s Digital Health Technology Could Be a True Game-Changer
AI-ML Innovations Inc.
Let’s be honest. The last thing we want to worry about is our health or the high costs of care.
That’s why many people are turning to digital health solutions.
Due to the recent health scare, governments and healthcare systems worldwide may now realize how essential digital health has become. But, as noted by Forbes, it’s also playing an indispensable role in providing higher quality, easily accessible, and affordable care.(6)
Health Gauge is a leading digital health solutions provider in a potential $312.6 billion global digital health monitoring market.(A) It already looks poised to transform the traditional healthcare industry by providing AI innovations and services that improve health outcomes.(1) All while reducing costs and stresses on the overburdened healthcare infrastructure.(1)
Unfortunately, There are Massive Problems in the Healthcare Industry
The multi-trillion-dollar U.S. healthcare market is broken.
It is a fragmented system with a lack of coordination, often resulting in inefficient resource allocation.
On top of that, rising health care costs are forcing many patients to spend money on ineffective solutions. Finally, however, there may be a solution.
Digital health solutions may save the healthcare industry billions of dollars – and give caregivers, patients, and health professionals easy access to necessary health data far quicker.
For example, with Health Gauge:
It’s similar to what Livongo Health offered before it was acquired by Teladoc Health in an approximately $18.5 billion deal.(1)
In fact, Livongo used technology to aggregate data about patients’ chronic conditions (diabetes – with plans for hypertension, weight management, and behavioral health) and then interpret the data to “create actionable, personalized and timely health signals.”(1)
However, according to Health Gauge, its platform includes more automation, so there’s less possibility of human error, AI-powered analysis, and a broader range of applicability.
Even better, Health Gauge successfully displayed its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation, further validating its technology.
The study concluded:(2)
Physicians, other healthcare professionals, and individuals can apply and adapt the Health Gauge solution to a number of different health conditions and settings for personal health monitoring and management – showing the larger value of Health Gauge’s device and applications.
Blood pressure related pregnancy maladies are of concern globally, and a leading cause of death amongst pregnant women. Health Gauge’s products have both the ability and opportunity to capitalize on this critical women’s health issue, while providing an invaluable service that has a direct impact on health outcomes.”
With It, AI/ML Innovations Can Address a Market Valued at Over $300B
The parent company of Health Gauge, AI/ML Innovations Inc., has realigned its business operations to capitalize on the burgeoning areas of artificial intelligence (AI) and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space with wearable technology.
Health Gauge may be on course to become one of the world’s leading digital health solutions providers. All as it moves to transform traditional healthcare with AI innovations and services that could improve health outcomes. Not to mention, it could be a perfect solution to help reduce the overall costs of a severely overburdened healthcare system in the process.
Better, Health Gauge is pushing into a potential $312.6 billion global digital health monitoring market by partnering with leading channel partners, health benefits providers, and end-users through a proprietary combination of digital health monitoring devices, AI-based software, and cloud computing platforms.
Health Gauge also appears to have a significant competitive advantage.
Smart Acquisitions Helping to Drive Growth for AI/ML
AI/ML just announced that it has entered into a binding Letter of Intent, subject to certain terms and conditions, regarding a strategic partnership and equity interest in the Paris, France based company, Tech2Health.
Tech2Health is well positioned to provide support for the current mental health pandemic, utilizing a unique blend of proprietary digital assets, remote live counselling, and a physical wellness center.
- Lead contract recently signed with a French multinational manufacturer, to provide mental wellness support to their 170,000 employees globally.
- Multiple pilot studies are pending with world-class medical facilities and insurers in Europe and South America.
- Historical track record/proof of business model – the Founders of Tech2Health utilized an earlier version of their digital wellness platform model to generate historical revenues totalling US$4.2 million, while providing services to leading health insurers such as Malakoff Humanis, Groupe Mutuel, Mapa, Apicil, and others.
Tech2Health is a digital healthcare innovator with a basket of wellness and health-tech products and services designed to improve an individual’s mental well-being by utilizing a unique blend of proprietary digital assets, remote live counselling, and a physical wellness center. Tech2Health has developed a clinically supported and evidence-based methodology consisting of psychotherapies and non-medicinal interventions that apply body and mind healing techniques supported by meditation, relaxation, mindfulness, yoga, sophrology and art therapy, delivered through a secure digital platform.
Strong Management, Strong Results – AI/ML Innovations Inc.
Randy Duguay, P.Eng, M.Eng
CEO & Founder
Former Senior Business leader at Canada’s most significant digital health services company – TELUS Health, Lead on several multi-million $ commercialized products and ventures reviews
Bruce Matichuk, B.Sc, M.Sc.
CTO & Founder
CTO of AI Tech companies, Lead multiple teams as CTO in new AI/ML innovations, Raised millions in private money
Amir Pournijab, B.Sc (Engineering), M.Sc. (Comp.Sci)
Application Development, JIRA Lead, Architecture & Software Development
Over the past 25 years, Mr. Daniels has held the positions of Chairman, Director, CEO and CFO for several Canadian and US-based, private and publicly traded technology, biomedical and strategic hi-tech mineral companies. Mr. Daniels’ extensive management experience includes a focus on corporate finance, strategic planning, project development and corporate governance matters. Mr. Daniels has led in the raising of many tens of millions of dollars for various projects and companies over the course of his career. Prior to his involvement in public companies, Mr. Daniels spent 8 productive years in the investment industry as a licensed stockbroker, assistant manager, and an integral member of the new underwritings team. Mr. Daniels holds a Bachelor of Commerce degree, with a major in Corporate Finance from the University of Saskatchewan.
Randy has a B.Sc. (Electrical / Computer Engineering), an M.Eng. (Management), and completed Exec development programs at UofT (Rotman Business School). Randy served in executive management with TELUS Health Solutions, Canada’s most significant digital health services company. There, Randy was lead on several multi-million dollar commercialized products ventures reviews and product development. Prior to his work in digital health solutions, Randy worked on leading-edge initiatives on Smart Communities initiatives, and as a senior project leader in services development for Canada’s top telecommunications companies as part of Stentor. Randy is also currently serving on the industry advisor board with the University of Alberta’s ST Innovations Group, and as an advisor to the UofAlberta Faculty of Engineering POD program.
Bruce has a M.Sc. (Comp.Science) and over 25 years of experience in managing innovative teams and deploying cutting edge software technology. Bruce has extensive background in machine learning, Artificial Intelligence, and software engineering. Bruce served as CTO of AI Tech companies that raised millions of dollars in private money.
John Cook has more than 45 years of professional experience in all facets of mining development, operations and management. John Cook was Chairman of Wolfden Resources Inc. until its purchase by Zinifex Limited in June, 2007 and then Chairman of Premier Gold until May of 2010. He has been the President of Tormin Resources Limited, a private mining company since May 1995, and is a graduate of Sheffield University in mining engineering.
Health Gauges’ Advisory Board Members
Dr. Pierre Boulanger, P.Eng , PhD, University of Alberta
Dr. Boulanger is a Professor and Cisco Chair in Healthcare, at the University of Alberta. He holds a double appointment of Professor at the University of Alberta’s Department of Computing Science (where he is the Director of the Advanced Man-Machine Interface Laboratory) and the Department of Radiology and Diagnostic Imaging. He is also on the editorial board of two major academic journals and sits on several international academic committees. His scientific research topics include new techniques for tele- medicine; patient specific modeling using sensor fusion; the application of tele-presence technologies applied to aged care facilities and remote regions; the application of AR/VR technologies to medical training, simulation, and collaborative diagnostics; and patient-specific modeling in surgery. Dr. Boulanger has accumulated more than 38 years of experience in 3D computer vision, rapid product development, and the applications of virtual reality systems in medical and industrial manufacturing.
Dr. Jacques Kpodonu, MD, FACC
Dr. Kpodonu is a triple US boarded cardiac and endovascular surgeon based at the Beth Israel Deaconess Medical Center and surgical faculty at Harvard Medical School. Additionally, he is a visionary clinician, medical scientist, and the lead author and editor of four medical textbooks as well as having regularly published work on topics including digital health, biomedical innovation, design of hybrid operating rooms. Dr. Kpodonu holds leadership roles with the Society of Thoracic Surgery, American College of Cardiology, REACH program and is frequently quoted in national and international journals and media like the Orange County Register and CTSNET. Dr. Kpodonu’s areas of professional expertise and interest include digital health technology, biomedical innovation, innovations in cardiac surgery, global health innovation, and precision medicine.
Source A: https://www.marketdataforecast.com/market-reports/digital-healthcare-market
Source 1: https://aiml-innovations.com/for-investors/ (Investor deck)
Source 2: https://aiml-innovations.com/wp-content/uploads/2021/02/PR-1-26-21.pdf
Source 3: https://www.wsj.com/articles/digital-health-startups-are-booming-their-customers-are-overwhelmed-11620039601
Source 4: https://www.investopedia.com/insights/why-healthcare-broken-us/
Source 5: https://pubmed.ncbi.nlm.nih.gov/20088632/
Source 6: https://www.forbes.com/sites/forbestechcouncil/2021/05/20/three-important-lessons-to-improve-digital-health-delivery/?sh=73c6f09c5c4f
This website / media webpage is owned, operated and edited by TD Media LLC. Any wording found on this website / media webpage or disclaimer referencing to “I” or “we” or “our” or “TD Media” refers to TD Media LLC. This website / media webpage is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies. By reading our website / media webpage you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage.We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website / media webpage are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our website / media webpage may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. TD Media business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our Websites, Email, SMS, Push Notifications, Influencers, Social Media Postings, Ticker Tags, Press Releases, Online Interviews, Podcasts, Videos, Audio Ads, Banner Ads, Native Ads, Responsive Ads. This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, TD Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 06/14/2021 and ending on 06/14/2021 to publicly disseminate information about (AIMLF:US) (AIML:CA) via digital communications. We have paid this Influencer one hundred dollars USD.
Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 06/15/2021 and ending on 06/15/2021 to publicly disseminate information about (AIMLF:US) (AIML:CA) via digital communications. We have paid this Influencer one hundred fifty dollars USD.
Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 06/16/2021 and ending on 06/16/2021 to publicly disseminate information about (AIMLF:US) (AIML:CA) via digital communications. We have paid this Influencer eight hundred dollars USD.
Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 06/16/2021 and ending on 06/18/2021 to publicly disseminate information about (AIMLF:US) (AIML:CA) via digital communications. We have paid this Influencer five hundred dollars USD.
Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 06/16/2021 and ending on 06/16/2021 to publicly disseminate information about (AIMLF:US) (AIML:CA) via digital communications. We have paid this Influencer two hundred fifty dollars USD.
Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 06/28/2021 and ending on 06/28/2021 to publicly disseminate information about (AIMLF:US) (AIML:CA) via digital communications. We have paid this Influencer one thousand three hundred dollars USD.
Pursuant to an agreement between TD Media LLC and Winning Media LLC, TD Media LLC has been hired for a period beginning on 06/14/2021 and ending on 08/31/2021 to publicly disseminate information about (AIMLF:US) (AIML:CA) via digital communications. We have been paid two hundred fifty thousand dollars USD via bank wire transfer.
Address: 82 Richmond St East Suite 200 Toronto ON M5C 1P1 CA
Phone: +1 (250) 384-1999
A leading digital health solutions provider poised to disrupt the traditional healthcare industry by providing AI innovations and services which improve health outcomes while reducing costs and stresses on the overburdened healthcare infrastructure.